UK markets close in 5 hours 8 minutes

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
881.10+22.70 (+2.64%)
As of 12:21PM CET. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
167,195,000
140,800,000
126,946,000
122,021,000
111,831,000
Cost of revenue
26,427,000
23,658,000
20,932,000
20,088,000
17,617,000
Gross profit
140,768,000
117,142,000
106,014,000
101,933,000
94,214,000
Operating expenses
Research development
21,594,000
17,772,000
15,462,000
14,220,000
14,805,000
Selling general and administrative
48,415,000
41,058,000
36,886,000
35,830,000
33,313,000
Total operating expenses
69,412,000
58,498,000
51,888,000
49,450,000
46,966,000
Operating income or loss
71,356,000
58,644,000
54,126,000
52,483,000
47,248,000
Interest expense
7,028,000
289,000
390,000
220,000
85,000
Total other income/expenses net
-
616,000
-793,000
-3,494,000
473,000
Income before tax
65,859,000
59,080,000
53,130,000
48,553,000
47,615,000
Income tax expense
13,034,000
11,323,000
10,992,000
9,602,000
8,987,000
Income from continuing operations
52,825,000
47,757,000
42,138,000
38,951,000
38,628,000
Net income
52,825,000
47,757,000
42,138,000
38,951,000
38,628,000
Net income available to common shareholders
52,825,000
47,757,000
42,138,000
38,951,000
38,628,000
Basic EPS
-
20.79
18.05
16.41
15.96
Diluted EPS
-
20.74
18.01
16.38
15.93
Basic average shares
-
2,297,114
2,333,900
2,374,299
2,419,603
Diluted average shares
-
2,302,652
2,340,000
2,378,658
2,424,417
EBITDA
-
65,394,000
59,273,000
54,434,000
51,625,000